Factors affecting power of tests for multiple binary outcomes

Statistics in Medicine

Volumn 29, Issue 28, 2010, Pages 2890-2904

  Mascha, Edward J ^a   Imrey, Peter B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Clinical trials; Composite outcomes; Correlated binary outcomes; Generalized estimating equations; Multivariate binary data; Relative efficiency

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; COLLOID; CONCEPTUAL FRAMEWORK; CORRELATION COEFFICIENT; CRITERION VARIABLE; CRYSTALLOID; DRUG EFFICACY; HUMAN; INTERNAL CONSISTENCY; LONGITUDINAL STUDY; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MULTIVARIATE ANALYSIS; POWER OF A TEST; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SAMPLE SIZE; SENSITIVITY ANALYSIS; SIMULATION; STATISTICAL MODEL; TREATMENT OUTCOME;

BIOSTATISTICS; FLUID THERAPY; HUMANS; MODELS, STATISTICAL; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 78649614785     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4066     Document Type: Article

References (44)

1. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? Journal of the American Medical Association 2003; 289(19):2554-2559. DOI: 10.1001/jama.289.19.2554.
2. Neaton J, Gray G, Zuckerman B, Konstam M. Key issues in end point selection for heart failure trials: composite end points. Journal of Cardiac Failure 2005; 11(8):567-575. DOI: 10.1016/j.cardfail.2005.08.350.
3. Chi G. Some issues with composite endpoints in clinical trials. Fundamental and Clinical Pharmacology 2005; 19(6):609-619. DOI: 0.1111/j.1472-8206.2005.00370.x.
4. Ferreira-González I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, Alonso-Coello P, Alonso J, Worster A, Upadhye S, Jaeschke R, Schünemann HJ, Permanyer-Miralda G, Pacheco-Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt GH. Problems with use of composite end points in cardiovascular trials: systematic review of randomized controlled trials. British Medical Journal 2007; 334(7597):786. DOI: 10.1136/bmj.39136.682083.AE.
5. Lim E, Brown A, Helmy A, Mussa S, Altman D. Composite outcomes in cardiovascular research: a survey of randomized trials. Annals of Internal Medicine 2008; 149:612-617.
6. Tomlinson G, Detsky A. Composite end points in randomized trials: there is no free lunch. Journal of the American Medical Association 2010; 303(3):267-268. DOI: 10.1001/jama.2009.2017.
7. Sankoh A, D'Agostino R, Huque M. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues. Statistics in Medicine 2003; 22(29):3133-3150. DOI: 10.1002/sim.1557.
8. Westfall P, Young S. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustments. Wiley: New York, 1993.
9. Westfall PH, Wolfinger RD. Multiple tests with discrete distributions. The American Statistician 1997; 51(1):3-8.
10. Liang K-Y, Zeger Scott L. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73(1):13-22.
11. Zeger Scott L, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42(1):121-130.
12. Coull BA, Hobert JP, Ryan LM, Holmes LB. Crossed random effect models for multiple outcomes in a study of teratogenesis. Journal of the American Statistical Association 2001; 96(456):1194-1204.
13. Legler JM, Ryan LM. Latent variable models for teratogenesis using multiple binary outcomes. Journal of the American Statistical Association 1997; 92(437):13-20.
14. Sammel MD, Ryan LM, Legler JM. Latent variable models for mixed discrete and continuous outcomes. Journal of the Royal Statistical Society Series B (Methodological) 1997; 59(3):667-678.
15. Teixeira-Pinto A, Normand S-LT. Correlated bivariate continuous and binary outcomes: issues and applications. Statistics in Medicine 2009; 28(13):1753-1773. DOI: 10.1002/sim.3588.
16. Prentice RL, Zhao LP. Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses. Biometrics 1991; 47(3):825-839.
17. Lefkopoulou M, Ryan L. Global tests for multiple binary outcomes. Biometrics 1993; 49(4):975-988.
18. Legler JM, Lefkopoulu Myrto, Ryan Louise M. Efficiency and power of tests for multiple binary outcomes. Journal of the American Statistical Association 1995; 90(430):680-693.
19. O'Brien P. Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40:1079-1087.
20. Westfall P, Tobias R, Rom D, Wolfinger R, Hochberg Y. Multiple Comparisons and Multiple Tests Using the SAS System. SAS Institute: Cary, NC, 1999.
21. Bull SB. Regression models for multiple outcomes in large epidemiologic studies. Statistics in Medicine 1998; 17(19):2179-2197.
22. Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, Devereaux PJ, Guyatt GH, Alonso-Coello P, Montori VM. Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials. Annals of Internal Medicine 2009; 150(8):566-567.
23. Turk D, Dworkin R, McDermott M, Bellamy N, Burke L, Chandler J, Cleeland C, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Pain 2008; 139(3):485-493. DOI: 10.1016/j.pain.2008.06.025.
24. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979; 6(2):65-70.
25. Lehmacher W, Wassmen G, Reitmeir P. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. Biometrics 1991; 47:511-521.
26. Leon AC, Heo M. A comparison of multiplicity adjustment strategies for correlated binary endpoints. Journal of Biopharmaceutical Statistics 2005; 15(5):839-855. DOI: 10.1081/BIP-200067922.
27. Wassmera G, Reitmeirb P, Kieserc M, Lehmachera W. Procedures for testing multiple endpoints in clinical trials: an overview. Journal of Statistical Planning and Inference 1999; 82:69-81.
28. Pocock Stuart J, Geller Nancy L, Tsiatis Anastasios A. The analysis of multiple endpoints in clinical trials. Biometrics 1987; 43(3):487-498.
29. Boos DD. On generalized score tests. The American Statistician 1992; 46(4):327-333.
30. Rotnitzky A, Jewell Nicholas P. Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data. Biometrika 1990; 77(3):485-497.
31. Tilley B, Marler J, Geller N, Lu M, Legler J, Brott T, Lyden P, Grotta J, for the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial Study Group. Use of a global test for multiple outcomes in stroke trials with application to the national institute of neurological disorders and stroke t-PA stroke trial. Stroke 1996; 27:2136-2142.
32. Fitzmaurice GM. A caveat concerning independence estimating equations with multivariate binary data. Biometrics 1995; 51(1):309-317.
33. Stram DO, Wei LJ, Ware JH. Analysis of repeated ordered categorical outcomes with possibly missing observations and time-dependent covariates. Journal of the American Statistical Association 1988; 83:631-637.
34. Oman Samuel D, Zucker David M. Modeling and generating correlated binary variables.Biometrika 2001 88(1):287-290.
35. Oman Samuel D. Easily simulated multivariate binary distributions with given positive and negative correlations. Computational Statistics and Data Analysis 2009; 53(4):999-1005. DOI: 10.1016/j.csda.2008.11.017.
36. Bahadur RR. A representation of the joint distribution of responses to n dichotomous items. In Studies in Item Analysis and Prediction, Solomon H (ed.). Stanford University Press: Stanford, 1961; 158-168.
37. Prentice RL. Correlated binary regression with covariates specific to each binary observation. Biometrics 1988; 44:1033-1048.
38. Frechet M. Sur les tableaux de correlation dont les marges et des bornes sont donnees. Revue Inst de Statistique 1960; 28:10-32.
39. NINDS. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine 1995; 333(24):1581-1588.
40. Montori V, Permanyer G, Ferreira I, Busse J, Pacheco-Huergo V, Bryant D, Alonso J, Akl E, Domingo-Salvany A, Mills E, Wu P, Schünemann HJ, Jaeschke R, Guyatt G. Validity of composite end points in clinical trials. British Medical Journal 2009; 330:3. DOI: 10.1136/bmj.330.7491.594.
41. Pocock S. Clinical trials with multiple outcomes: a statistical perspective on their design, analysis and interpretation. Controlled Clinical Trials 1997; 18:530-545.
42. Dahmen G, Rochon J, König IR, Ziegler A. Sample size calculations for controlled clinical trials using generalized estimating equations (GEE). Methods of Information in Medicine 2004; 43(5):451-456.
43. Pan W. Sample size and power calculations with correlated binary data. Controlled Clinical Trials 2001; 22(3):211-227.
44. Follmann D, Wittes J, Cutler JA. The use of subjective rankings in clinical trials with an application to cardiovascular disease. Statistics in Medicine 1992; 11(4):427-437.